Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

WASHINGTON, June 20, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the JMP Securities Life Sciences Conference in New York City on Tuesday, June 21, 2016 at 3:30 p.m. Eastern Time.

The presentation at the JMP Securities Life Sciences Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page.  Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc. Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:Jim Kelly Senior Vice President and Chief Financial Officer Vanda Pharmaceuticals Inc.(202) 734-3428[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-jmp-securities-life-sciences-conference-300287325.html

SOURCE Vanda Pharmaceuticals Inc.